These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1758848)

  • 1. [Effects of the PAF antagonist WEB 2086 on hypoxia and angiotensin II-induced pulmonary vasoconstriction in the isolated perfused rat lung].
    Kempfert C; Brandt R; Siewert B; Kanowski U; Oddoy A
    Pneumologie; 1991 Oct; 45(10):799-803. PubMed ID: 1758848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
    Chen CR; Voelkel NF; Chang SW
    J Appl Physiol (1985); 1992 Nov; 73(5):1762-9. PubMed ID: 1474049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence against a role for platelet-activating factor in hypoxic pulmonary vasoconstriction in the rat.
    McCormack DG; Barnes PJ; Evans TW
    Clin Sci (Lond); 1989 Oct; 77(4):439-43. PubMed ID: 2805602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor: evidence against a role in hypoxic pulmonary vasoconstriction.
    McCormack DG; Barnes PJ; Evans TW
    Crit Care Med; 1990 Dec; 18(12):1398-402. PubMed ID: 2245615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor antagonists increase vascular reactivity in perfused rat lungs.
    Haynes J; Chang SW; Morris KG; Voelkel NF
    J Appl Physiol (1985); 1988 Nov; 65(5):1921-8. PubMed ID: 3209541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats.
    Ono S; Westcott JY; Voelkel NF
    J Appl Physiol (1985); 1992 Sep; 73(3):1084-92. PubMed ID: 1400021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAF potentiates protamine-induced lung edema: role of pulmonary venoconstriction.
    Chen CR; Voelkel NF; Chang SW
    J Appl Physiol (1985); 1990 Mar; 68(3):1059-68. PubMed ID: 2341334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor-induced coronary constriction in the isolated perfused guinea pig heart and antagonistic effects of the PAF antagonist WEB 2086.
    Felix SB; Steger A; Baumann G; Busch R; Ochsenfeld G; Berdel WE
    J Lipid Mediat; 1990; 2(1):9-20. PubMed ID: 2133268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart.
    Hu W; McNicholl IK; Choy PC; Man RY
    Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained effects of platelet-activating factor infusion in piglets.
    Stambouly JJ; Bradley LM; Czaja JF; Goldstein RE
    Pediatr Res; 1991 Sep; 30(3):261-5. PubMed ID: 1945566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of exercise-training on hypoxia and angiotensin II-induced pulmonary vasoconstrictions.
    Kashimura O; Sakai A; Yanagidaira Y
    Acta Physiol Scand; 1995 Nov; 155(3):291-5. PubMed ID: 8619327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of platelet activating factor on vascular responsiveness in isolated rat lungs.
    Gillespie MN; Bowdy BD
    J Pharmacol Exp Ther; 1986 Feb; 236(2):396-402. PubMed ID: 3944767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic pulmonary vasoconstriction in isolated blood-perfused rat lung; modulation by thromboxane A2, platelet-activating factor, cysteinyl leukotrienes and endothelin-1.
    Chłopicki S; Bartuś JB; Gryglewski RJ
    Pol J Pharmacol; 2002; 54(5):433-41. PubMed ID: 12593530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Aminopyridine restores impaired hypoxic pulmonary vasoconstriction in endotoxemic mice.
    Spöhr F; Busch CJ; Reich C; Motsch J; Gebhard MM; Kuebler WM; Bloch KD; Weimann J
    Anesthesiology; 2007 Oct; 107(4):597-604. PubMed ID: 17893456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin-induced lung injury in rats selectively abolishes hypoxic pulmonary vasoconstriction: evidence against a role for platelet-activating factor.
    McCormack DG; Crawley DE; Barnes PJ; Evans TW
    Clin Sci (Lond); 1992 Mar; 82(3):259-64. PubMed ID: 1372199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchial and vascular effects of Paf in the rat isolated lung are completely blocked by WEB 2086, a novel specific Paf antagonist.
    Casals-Stenzel J; Franke J; Friedrich T; Lichey J
    Br J Pharmacol; 1987 Aug; 91(4):799-802. PubMed ID: 3664079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats.
    Liu SF; Crawley DE; Barnes PJ; Evans TW
    Am Rev Respir Dis; 1991 Jan; 143(1):32-7. PubMed ID: 1986681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Intralipid on hypoxic and angiotensin-II induced pulmonary vasoconstriction in the isolated rat lung.
    Baudouin SV; Messent M; Evans TW
    Crit Care Med; 1994 Dec; 22(12):1964-8. PubMed ID: 7988134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin, hypoxia, verapamil and pulmonary vessels.
    Suggett AJ; Mohammed FH; Barer GR
    Clin Exp Pharmacol Physiol; 1980; 7(3):263-74. PubMed ID: 7398135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.